Module Database

Information for module PHAR3031

This module is available for: The current academic year and The next academic year(provisional)

If you're a member of UCL you can add this module to your personalised course list

This information is for guidance only. If you are a UCL undergraduate interested in studying one of these courses, you must seek permission from both the providing department and your 'home' department. Appearance in this database is not a guarantee that a course is running in any particular academic year.


Module code:PHAR3031(Add to my personalised list)
Title:Immunopharmacology
Credit value:.5
Division:Division of Biosciences
Module organiser:D. Willis
Organiser's location:GM05
Organiser's email:dean.willis@ucl.ac.uk
Available for students in Year(s):3,
Module prerequisites:2nd Year Pharmacology (PHAR2002 [B15], Preclinical. Students who have taken other courses should consult the course organiser 
Module outline:As our knowledge of human disease increases it is becoming evident that inflammation plays a significant part in many pathologies. The diseases in which inflammation has a major role, not only includes the classical inflammatory diseases, such as asthma, arthritis, allergies and the auto-immune pathologies, but also atherosclerosis, ischemic-reperfusion injury, sepsis/multiply organ failure and COPD. Inflammation is also an important component of metabolic diseases, with evidence suggesting a link between diabetes obesity and inflammation, is an important of tumor genesis and is the underlying mechanism by which transplants are rejected. This course provides in-depth coverage of the core mechanism by which inflammation is initiated and maintained and discusses the state of the current and future research trends in its treatment. 
Module aims:The aim of immunopharmacology is provide up-to-date information on the pharmacology of the mediators and cells which drive inflammation, how they interact to provide a robust response, and how dysfunctions in these pathways lead to pathology. The course will also describe currently used anti-inflammatory drugs and investigate future trends in this area of pharmacological research.  
Module objectives:• To know which cells and mediators are key in the development of an inflammatory response. • To understand the criteria used to assess whether or not endogenous substances may be described as mediator of inflammation. • To be able to explain the mechanism of action of drugs which are used to control the inflammatory process. • To appreciate current trends in inflammatory mediator and anti-inflammatory drug research • To understand in particular the pathology of asthma and rheumatoid arthritis and the therapeutic approaches towards these diseases • To develop your skills in literature searches, literature/research evaluation, study design and presentation of a research proposal.  
Key skills provided by module:In addition to providing an update overview of immunopharmacology, the course aims to provide the skills which are required when formulating, justifying and presenting a project. These skills not only have relevance to the preparation of research proposals/grants but also to general project management proposals and in formulating and preparation of business plans.  
Module timetable:https://cmis.adcom.ucl.ac.uk:4443/timetabling/moduleTimet.do?firstReq=Y&moduleId=PHAR3031 
Module assessment:Unseen two-hour written examination 75.00%.
1 essay of 3000 words 25.00%.
 
Notes: 
Taking this module as an option?: 
Link to virtual learning environment(registered students only)http://www.ucl.ac.uk/lifesciences-faculty/degree-programmes/pharmacology/modules 
Last updated:2008-09-30 13:15:47 by ucklrom